<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>He D</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To evaluate the efficacy and safety of the Peiyu Granules (PYG) compared with placebo on early miscarriage rates among women undergoing embryo transfer.&lt;h4>Methods&lt;/h4>A double-blind, parallel-group randomized clinical trial between February 15, 2017, and June 17, 2019, within 10 months of pregnancy follow-up until March 2020. This clinical trial was conducted at Beijing Obstetrics and Gynecology Hospital, Capital Medical University. A total of 886 women were included in this study. The intervention group (n = 443) received PYG on the night of Embryo Transfer (ET) until the day of the hCG test. If it was negative, the patient stopped taking medicine. In contrast, the treatment continued until 70 days after ET. The women in the control group (n = 443) consumed the same amo</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>1631313</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12457714</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effect of the Peiyu granules on early miscarriage among women undergoing embryo transfer: a randomized, double-blind, placebo-controlled trial.</pubmed_title><pmcid>PMC12457714</pmcid><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>He D</pubmed_authors><pubmed_authors>Jia C</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>Lan Y</pubmed_authors><pubmed_authors>Dai Y</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Ma C</pubmed_authors><pubmed_authors>Yin C</pubmed_authors><pubmed_authors>Lyu T</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Yue W</pubmed_authors><pubmed_authors>Liu D</pubmed_authors><pubmed_authors>Wu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of the Peiyu granules on early miscarriage among women undergoing embryo transfer: a randomized, double-blind, placebo-controlled trial.</name><description>&lt;h4>Objective&lt;/h4>To evaluate the efficacy and safety of the Peiyu Granules (PYG) compared with placebo on early miscarriage rates among women undergoing embryo transfer.&lt;h4>Methods&lt;/h4>A double-blind, parallel-group randomized clinical trial between February 15, 2017, and June 17, 2019, within 10 months of pregnancy follow-up until March 2020. This clinical trial was conducted at Beijing Obstetrics and Gynecology Hospital, Capital Medical University. A total of 886 women were included in this study. The intervention group (n = 443) received PYG on the night of Embryo Transfer (ET) until the day of the hCG test. If it was negative, the patient stopped taking medicine. In contrast, the treatment continued until 70 days after ET. The women in the control group (n = 443) consumed the same amo</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-03T20:14:16.36Z</modification><creation>2026-05-01T03:11:09.437Z</creation></dates><accession>S-EPMC12457714</accession><cross_references><pubmed>41001675</pubmed><doi>10.3389/fendo.2025.1631313</doi></cross_references></HashMap>